Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity.

Zehra KaraRüveyda AkçinAhmet Numan DemirHarika Öykü DinçHalit Eren TaşkınBekir KocazeybekVolkan Demirhan Yumuk

Published in: Obesity surgery (2022)

Patients with severe obesity generated significantly reduced antibody titers against SARS-CoV-2 spike antigen after CoronaVac and BNT162b2 vaccines compared to people with normal weight. Antibody levels in patients with severe obesity vaccinated with BNT162b2 were found to be significantly higher than those vaccinated with CoronaVac. People living with severe obesity should be prioritized for COVID-19 vaccination and BNT162b2 vaccine may be recommended for this vulnerable population.

Keyphrases

sars cov
weight loss
insulin resistance
metabolic syndrome
weight gain
type diabetes
high fat diet induced
early onset
respiratory syndrome coronavirus
coronavirus disease
body mass index
physical activity